OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial
Peter C. Taylor, Didier Saurigny, Jiří Vencovský, et al.
Arthritis Research & Therapy (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 78
Peter C. Taylor, Didier Saurigny, Jiří Vencovský, et al.
Arthritis Research & Therapy (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 78
Showing 26-50 of 78 citing articles:
Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study
Christopher D. Buckley, Jesus Abraham Simón Campos, Вячеслав Миколайович Ждан, et al.
The Lancet Rheumatology (2020) Vol. 2, Iss. 11, pp. e677-e688
Open Access | Times Cited: 34
Christopher D. Buckley, Jesus Abraham Simón Campos, Вячеслав Миколайович Ждан, et al.
The Lancet Rheumatology (2020) Vol. 2, Iss. 11, pp. e677-e688
Open Access | Times Cited: 34
Monocytes and Macrophages in Spondyloarthritis: Functional Roles and Effects of Current Therapies
Sara Martínez-Ramos, Carlos Rafael‐Vidal, José María Pego‐Reigosa, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 515-515
Open Access | Times Cited: 21
Sara Martínez-Ramos, Carlos Rafael‐Vidal, José María Pego‐Reigosa, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 515-515
Open Access | Times Cited: 21
Immunotherapies in chronic pain through modulation of neuroimmune interactions
Junli Zhao, Yul Huh, Andrey V. Bortsov, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108476-108476
Open Access | Times Cited: 13
Junli Zhao, Yul Huh, Andrey V. Bortsov, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108476-108476
Open Access | Times Cited: 13
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3)
Peter C. Taylor, Michael E. Weinblatt, Iain B. McInnes, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 12, pp. 1527-1537
Open Access | Times Cited: 13
Peter C. Taylor, Michael E. Weinblatt, Iain B. McInnes, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 12, pp. 1527-1537
Open Access | Times Cited: 13
Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya
Fok‐Moon Lum, Yi‐Hao Chan, Teck‐Hui Teo, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 3, pp. 641-663
Open Access | Times Cited: 4
Fok‐Moon Lum, Yi‐Hao Chan, Teck‐Hui Teo, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 3, pp. 641-663
Open Access | Times Cited: 4
Saharan dust induces the lung disease-related cytokines granulocyte–macrophage colony-stimulating factor and granulocyte colony-stimulating factor
Gerrit Bredeck, Jochen Dobner, Andrea Rossi, et al.
Environment International (2024) Vol. 186, pp. 108580-108580
Open Access | Times Cited: 4
Gerrit Bredeck, Jochen Dobner, Andrea Rossi, et al.
Environment International (2024) Vol. 186, pp. 108580-108580
Open Access | Times Cited: 4
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations
Lavinia Agra Coletto, Chiara Rizzo, Giuliana Guggino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4108-4108
Open Access | Times Cited: 10
Lavinia Agra Coletto, Chiara Rizzo, Giuliana Guggino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4108-4108
Open Access | Times Cited: 10
What's new on the horizon for rheumatoid arthritis management
Karmtej Singh Cheema, Ali Mansour, Siba P. Raychaudhuri
Best Practice & Research Clinical Rheumatology (2025), pp. 102038-102038
Closed Access
Karmtej Singh Cheema, Ali Mansour, Siba P. Raychaudhuri
Best Practice & Research Clinical Rheumatology (2025), pp. 102038-102038
Closed Access
Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X)
Michael E. Weinblatt, Peter C. Taylor, Iain B. McInnes, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e088869-e088869
Open Access
Michael E. Weinblatt, Peter C. Taylor, Iain B. McInnes, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e088869-e088869
Open Access
Anti-GM-CSF Autoantibodies in Myeloid Leukemias
Анна Сергеева, Wingchi K. Leung, Lisa S. St. John, et al.
Best Practice & Research Clinical Haematology (2025) Vol. 38, Iss. 1, pp. 101611-101611
Closed Access
Анна Сергеева, Wingchi K. Leung, Lisa S. St. John, et al.
Best Practice & Research Clinical Haematology (2025) Vol. 38, Iss. 1, pp. 101611-101611
Closed Access
Identification of BHLHE40 ‐Expressing CD4 + T Cells Producing GM ‐CSF in Rheumatoid Arthritis
Sho Ishigaki, Katsuya Suzuki, Masaru Takeshita, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 4
Closed Access
Sho Ishigaki, Katsuya Suzuki, Masaru Takeshita, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 4
Closed Access
Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review
Wushu Chen, Xin Feng, L. Yao, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Wushu Chen, Xin Feng, L. Yao, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
GM-CSF impairs erythropoiesis by disrupting erythroblastic island formation via macrophages
Weijie Cao, Wenjuan Fan, Fang Wang, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Weijie Cao, Wenjuan Fan, Fang Wang, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Developmental drugs for sarcoidosis
Ogugua Ndili, Lesley Ann Saketkoo, Lisa A. Maier, et al.
Journal of Autoimmunity (2024) Vol. 149, pp. 103179-103179
Closed Access | Times Cited: 3
Ogugua Ndili, Lesley Ann Saketkoo, Lisa A. Maier, et al.
Journal of Autoimmunity (2024) Vol. 149, pp. 103179-103179
Closed Access | Times Cited: 3
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial
Claudia Worth, Hussein Al‐Mossawi, Jo-Anne MacDonald, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 8, pp. e537-e545
Open Access | Times Cited: 3
Claudia Worth, Hussein Al‐Mossawi, Jo-Anne MacDonald, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 8, pp. e537-e545
Open Access | Times Cited: 3
Preliminary Report on Interleukin-22, GM-CSF, and IL-17F in the Pathogenesis of Acute Anterior Uveitis
Jerry Chien‐Chieh Huang, Matthew Schleisman, Dongseok Choi, et al.
Ocular Immunology and Inflammation (2019) Vol. 29, Iss. 3, pp. 558-565
Open Access | Times Cited: 25
Jerry Chien‐Chieh Huang, Matthew Schleisman, Dongseok Choi, et al.
Ocular Immunology and Inflammation (2019) Vol. 29, Iss. 3, pp. 558-565
Open Access | Times Cited: 25
<p>Demethylation and Overexpression of CSF2 are Involved in Immune Response, Chemotherapy Resistance, and Poor Prognosis in Colorectal Cancer</p>
Zongbin Xu, Yiyi Zhang, Meifang Xu, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 11255-11269
Open Access | Times Cited: 25
Zongbin Xu, Yiyi Zhang, Meifang Xu, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 11255-11269
Open Access | Times Cited: 25
Translating the biology of β common receptor-engaging cytokines into clinical medicine
Harshita Pant, Timothy R. Hercus, Damon J. Tumes, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 2, pp. 324-344
Open Access | Times Cited: 14
Harshita Pant, Timothy R. Hercus, Damon J. Tumes, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 2, pp. 324-344
Open Access | Times Cited: 14
Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?
Stephanie R Harrison, Helena Marzo‐Ortega
Current Rheumatology Reports (2023) Vol. 25, Iss. 3, pp. 56-67
Open Access | Times Cited: 7
Stephanie R Harrison, Helena Marzo‐Ortega
Current Rheumatology Reports (2023) Vol. 25, Iss. 3, pp. 56-67
Open Access | Times Cited: 7
Proinflammatory cytokines and their receptors as druggable targets to alleviate pathological pain
Theodora Kalpachidou, Lydia Riehl, Clemens L. Schöpf, et al.
Pain (2022) Vol. 163, Iss. S1, pp. S79-S98
Closed Access | Times Cited: 12
Theodora Kalpachidou, Lydia Riehl, Clemens L. Schöpf, et al.
Pain (2022) Vol. 163, Iss. S1, pp. S79-S98
Closed Access | Times Cited: 12
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Jinsha Liu, Joey Ting, Shams Al-Azzam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2805-2805
Open Access | Times Cited: 15
Jinsha Liu, Joey Ting, Shams Al-Azzam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2805-2805
Open Access | Times Cited: 15
Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage
Julien Blaess, J. Walther, Arthur Petitdemange, et al.
Therapeutic Advances in Musculoskeletal Disease (2020) Vol. 12
Open Access | Times Cited: 15
Julien Blaess, J. Walther, Arthur Petitdemange, et al.
Therapeutic Advances in Musculoskeletal Disease (2020) Vol. 12
Open Access | Times Cited: 15
Nanotechnology as a promising platform for rheumatoid arthritis management: Diagnosis, treatment, and treatment monitoring
Parastou Rahimizadeh, Zahra Rezaieyazdi, Faezeh Behzadi, et al.
International Journal of Pharmaceutics (2021) Vol. 609, pp. 121137-121137
Closed Access | Times Cited: 14
Parastou Rahimizadeh, Zahra Rezaieyazdi, Faezeh Behzadi, et al.
International Journal of Pharmaceutics (2021) Vol. 609, pp. 121137-121137
Closed Access | Times Cited: 14
Drug repurposing for COVID-19: current evidence from randomized controlled adaptive platform trials and living systematic reviews
Yolanda Augustin, Henry M. Staines, Thirumalaisamy P. Velavan, et al.
British Medical Bulletin (2023) Vol. 147, Iss. 1, pp. 31-49
Open Access | Times Cited: 5
Yolanda Augustin, Henry M. Staines, Thirumalaisamy P. Velavan, et al.
British Medical Bulletin (2023) Vol. 147, Iss. 1, pp. 31-49
Open Access | Times Cited: 5
An Update on the Emerging Role of Wnt/β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis
Pradyuman Prajapati, Gaurav Doshi
Current Drug Targets (2023) Vol. 24, Iss. 17, pp. 1298-1316
Closed Access | Times Cited: 5
Pradyuman Prajapati, Gaurav Doshi
Current Drug Targets (2023) Vol. 24, Iss. 17, pp. 1298-1316
Closed Access | Times Cited: 5
